Waiver Remove Data For Free

Section 1262 of the 'Consolidated Appropriations Act of 2023' removes the federal requirement for practitioners to apply for a special waiver prior to prescribing buprenorphine for the treatment of opioid use disorder.

The Drug Addiction Treatment Act of 2000 (DATA 2000) permits qualified physicians to. prescribe buprenorphine (and other Schedule III, IV, and V narcotic medications) in. settings other than opioid treatment programs.

Drug Addiction Treatment Act of 2000 - Amends the Controlled Substances Act to waive the requirement that practitioners who dispense narcotic drugs to individuals for maintenance or detoxification treatment annually obtain a separate registration for that purpose, and that the Attorney General register an applicant to ...

Drug Addiction Treatment Act of 2000 - Amends the Controlled Substances Act to waive the requirement that practitioners who dispense narcotic drugs to individuals for maintenance or detoxification treatment annually obtain a separate registration for that purpose, and that the Attorney General register an applicant to ...

In terms of SUDs specifically, the goal of ACT is to help you accept urges to use substances and take healthier actions that may reduce the desire to misuse drugs or alcohol. ACT aims to accomplish this through the use of 6 core processes, which include: The present moment.

Physicians can take the follow- ing steps to apply for a DATA 2000 Waiver: Ensure you meet and have documentation showing you are a qualifying physician. Complete the required 8-hour training to pre- scribe and dispense buprenor- phine.

If you want to check your registration expiration date, please contact the DEA Registration Service Center at 1-800-882-9539 or email DEA.Registration.Help@usdoj.gov and include your DEA registration number in your email.

Each DATA Waived Physician (DWP) is responsible for notifying the Department of Health and Human Services' Substance Abuse and Mental Health Services Administration (SAMHSA) and DEA of a change in his/her primary practice address.

Under the Drug Addiction Treatment Act of 2000 (DATA 2000), physicians who have completed the mandatory eight-hour training course are now eligible to obtain a DEA-X waiver to administer and/or prescribe buprenorphine medication-assisted therapy to treat opioid use disorder.

A 30-level waiver allows providers who wish to treat up to 30 patients to prescribe Buprenorphine. For this level waiver, physicians need 8 hours of training and APRNs or PAs need 24 hours of training.